Nanoparticle: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
imported>David E. Volk
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 4: Line 4:
  | title = The Use of Nomenclature in Dispersion Science and Technology  
  | title = The Use of Nomenclature in Dispersion Science and Technology  
  | author = Vincent A. Hackley and Chiara F. Ferraris | date = August 2001
  | author = Vincent A. Hackley and Chiara F. Ferraris | date = August 2001
  | publisher = [[National Institute of Science and Technology]]}}, p.  4</ref>
  | publisher = [[National Institute of Standards and Technology]]}}, p.  4</ref> Because the optical properties of nanoparticles are a function of their sizes, mixtures of differently sized nanoparticles are being investigated for their ability to maximize energy conversion in solar panels. By using a variety of chemical functionalization and chemical etching techniques, their use as targeted delivery devices is increasingly being reported in the scientific literature.  Magnetic nanoparticles, which can be precisely relocated within living tissues, have recently been used in a number of promising new medical procedures. Particles decorated with surface antibodies or aptamers targeting to cancer-specific proteins have also shown promise in early research studies.
 
==Toxicology and environmental effects==
Possible toxic effects of nanoparticles are not fully understood. <ref>{{citation
| title = Toxicology of Pollution Particles
| author = Rodger Duffin
| url = http://www.nanoforum.org/dateien/temp/Rodger%20Duffin.pdf?07062006014351}}</ref>
==Life sciences applications==
==Life sciences applications==
Manufactured nanoparticles can be used for drug delivery, mimicking the behavior of cellular components such as:<ref>{{citation
Manufactured nanoparticles can be used for drug delivery, mimicking the behavior of cellular components and acting as "intracellular reservoirs for sustained
release of encapsulated therapeutic agent"  Components include:<ref>{{citation
  | title = Nanotechnology in the life sciences: Life sciences and medicine
  | title = Nanotechnology in the life sciences: Life sciences and medicine
  | publisher = Frontis Lecture Series
  | publisher = Frontis Lecture Series
  | author = Pieter Stroeve
  | author = Pieter Stroeve
  | url = http://nanoparticles.org/pdf/NANO5.pdf
  | url = http://nanoparticles.org/pdf/NANO5.pdf
}}, p. 26</ref>
}}, pp. 26-27</ref>


*[[vesicle]]s
*[[vesicle]]s

Latest revision as of 19:56, 4 April 2011

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In materials science, a nanoparticle is a member of a class of particles (or atomic clusters), which have average dimensions smaller than roughly 100 nm. They exhibit properties not normally associated with the bulk phase of materials, such as quantum optical effects.[1] Because the optical properties of nanoparticles are a function of their sizes, mixtures of differently sized nanoparticles are being investigated for their ability to maximize energy conversion in solar panels. By using a variety of chemical functionalization and chemical etching techniques, their use as targeted delivery devices is increasingly being reported in the scientific literature. Magnetic nanoparticles, which can be precisely relocated within living tissues, have recently been used in a number of promising new medical procedures. Particles decorated with surface antibodies or aptamers targeting to cancer-specific proteins have also shown promise in early research studies.

Toxicology and environmental effects

Possible toxic effects of nanoparticles are not fully understood. [2]

Life sciences applications

Manufactured nanoparticles can be used for drug delivery, mimicking the behavior of cellular components and acting as "intracellular reservoirs for sustained release of encapsulated therapeutic agent" Components include:[3]

They may be manufactured as:

  • coated solid particles
  • polymers
  • solid lipid nanoparticles

References